Unfinished Labeling Business: Pregnancy, In Vitro Data, Containers
Executive Summary
FDA's final labeling rule defers revisions to labeling issues such as the content and format of the Pregnancy subsection, inclusion of in vitro data and the requirements for container labels
You may also be interested in...
Pregnancy Label Due Date Approaching? Risk, Clinical Info Could Be Split
FDA is seeking to move ahead quickly with new regulations for pregnancy labeling following the release of the physician labeling final rule
Pregnancy Label Due Date Approaching? Risk, Clinical Info Could Be Split
FDA is seeking to move ahead quickly with new regulations for pregnancy labeling following the release of the physician labeling final rule
Labeling “Highlights” To Depend On Data In Relation To Clinical Setting
Information to be included in the new Highlights of Prescribing Information section of professional labeling will be determined by the clinical setting in which the drug is used, FDA said